Cargando…

Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure

Heart rate reduction using ivabradine, a selective I(f) channel blocker that purely decreases heart rate without affecting hemodynamics, improves clinical outcomes in patients with systolic heart failure. However, the ideal heart rate that should be a target remains unknown. Our team recently propos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imamura, Teruhiko, Kinugawa, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879967/ https://www.ncbi.nlm.nih.gov/pubmed/35208489 http://dx.doi.org/10.3390/medicina58020164

Ejemplares similares

Implications of Doppler Echocardiography-guided Heart Rate Modulation Using Ivabradine
por: Hori, Masakazu, et al.
Publicado: (2021)

Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure
por: Hori, Masakazu, et al.
Publicado: (2020)

Impact of Sodium Zirconium Cyclosilicate Therapy Cessation in Patients with Systolic Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2022)

How to consider target heart rate in patients with systolic heart failure
por: Izumida, Toshihide, et al.
Publicado: (2020)

Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Optimal Therapeutic Strategy Using Sacubitril/Valsartan in a Patient with Systolic Heart Failure and Chronic Kidney Disease - An Initial Case Report in Japan
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Successful Management of Osimertinib-Induced Heart Failure
por: Fukuo, Atsuko, et al.
Publicado: (2022)

Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Renal Function in Patient with Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Trans-Apical Transcatheter Aortic Valve Replacement in a Dialysis Patient with Systolic Heart Failure
por: Oshima, Akira, et al.
Publicado: (2022)

Drastic Cardiac Reverse Remodeling Following Catheter Ablation in Patients with Atrial Fibrillation and Heart Failure
por: Koi, Takahisa, et al.
Publicado: (2021)

Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Heart Failure with Preserved Ejection Fraction
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Acute Heart Failure in a Patient with Occult Barlow’s Disease Receiving Bevacizumab
por: Izumida, Toshihide, et al.
Publicado: (2021)

Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Initial Experience of Vericiguat Treatment in Patients with Heart Failure and Reduced Ejection Fraction
por: Nakamura, Makiko, et al.
Publicado: (2023)

Optimization of pressure settings during adaptive servo-ventilation support using real-time heart rate variability assessment: initial case report
por: Imamura, Teruhiko, et al.
Publicado: (2017)

Measurement of pulmonary arterial elastance in patients with systolic heart failure using Doppler echocardiography
por: Taghavi, Sepideh, et al.
Publicado: (2016)

Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogenic Hematopoietic Cell Transplantation
por: Henmi, Heisuke, et al.
Publicado: (2022)

Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis
por: Izumida, Toshihide, et al.
Publicado: (2021)

Chronotype of Lung Fluid Levels in Patients with Chronic Heart Failure
por: Ueno, Yohei, et al.
Publicado: (2022)

Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2016)

Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate
por: Oshima, Akira, et al.
Publicado: (2021)

Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine
por: Pereira-Barretto, Antonio Carlos
Publicado: (2016)

Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis
por: Anantha Narayanan, Mahesh, et al.
Publicado: (2017)

Combination Therapy Using Sodium Zirconium Cyclosilicate and a Mineralocorticoid Receptor Antagonist in Patients with Heart Failure and Hyperkalemia
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
por: Borer, Jeffrey S., et al.
Publicado: (2012)

Comment on: Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: Rationale and design of SHIFT‐AHF trial
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Implication of Mineralocorticoid Receptor Antagonist Esaxerenone in Patients With Heart Failure With Preserved Ejection Fraction
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Factors Associated with Recurrent Heart Failure during Incorporating SGLT2 Inhibitors in Patients Hospitalized for Acute Decompensated Heart Failure
por: Nakagaito, Masaki, et al.
Publicado: (2022)

Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I (f) Inhibitor Ivabradine Trial (SHIFT) Trial
por: Böhm, Michael, et al.
Publicado: (2016)

Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018)

Initial Real-World Practical Experience of Sacubitril/Valsartan Treatment in Japanese Patients With Chronic Heart Failure
por: Nakamura, Makiko, et al.
Publicado: (2021)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study
por: Cacciapuoti, Federico, et al.
Publicado: (2017)

Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart Failure
por: Nakagaito, Masaki, et al.
Publicado: (2023)

Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure
por: Chapman, Mimi, et al.
Publicado: (2021)

Comparison Between Ivabradine and Low-Dose Digoxin in the Therapy of Diastolic Heart Failure with Preserved Left Ventricular Systolic Function
por: Cocco, Giuseppe, et al.
Publicado: (2013)

Combination Therapy Using Pemafibrate and Dapagliflozin for Metabolic Dysfunction-associated Fatty Liver Disease
por: Imamura, Teruhiko, et al.
Publicado: (2022)

A case report of ivabradine used for heart rate control of atrial fibrillation in acute decompensated heart failure
por: Hardison, Edward, et al.
Publicado: (2022)

Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States
por: Borer, Jeffrey S., et al.
Publicado: (2016)

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
por: Franke, Jennifer, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hp8m66e90nikpn46plb95md5b3